Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 9
226
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Anti-inflammatory glycosides from the roots of Paeonia intermedia C. A. Meyer

, , , , , & show all
Pages 1452-1458 | Received 22 Apr 2019, Accepted 30 Jul 2019, Published online: 27 Aug 2019
 

Abstract

Three new phenolic glycosides, intermedia A–C (13), one new acyclic alcohol glycoside, intermedia D (4), together with 3 known glycosides (57), were isolated from the dried roots of Paeonia intermedia C. A. Meyer. Their structures were established by means of extensive spectroscopic analysis (HRESIMS, NMR). Compound 1 have a rare benzo[1,5]dioxepine skeleton. The bioassay results showed that compound 3 exhibited inhibitory activity against proinflammatory cytokines nitric oxide (NO) secretion in LPS-activated RAW264.7 cells with an IC50 value of 85.76 ± 1.36 μM.

Graphical Abstract

Acknowledgments

We thank Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Jinan University for the HRESIMS measurement.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the National Natural Science Foundation of China (Grant No. 81603275) and the China Postdoctoral Science Foundation (Grant No. 2016M602697, No. 2018T110988).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.